← Back to All US Stocks

Organigram Global Inc.. (OGI) Fundamental Analysis & AI Grade 2026

OGI Nasdaq Pharmaceutical Preparations Z4 CIK: 0001620737
Recently Updated • Analysis: Jul 13, 2026 • SEC Data: 2026-07-13

Organigram Global Inc.. (OGI) Financial Metrics & Key Ratios

Revenue
N/A
Net Income
N/A
EPS (Diluted)
$0.00
Free Cash Flow
N/A
Total Assets
N/A
Cash Position
N/A

💡 AI Analyst Insight

The current ratio below 1.0x warrants monitoring of short-term liquidity.

OGI Profit Margin, ROE & Profitability Analysis

Gross Margin N/A
Operating Margin N/A
Net Margin N/A
ROE N/A
ROA N/A
FCF Margin N/A

OGI vs Healthcare Sector: How Organigram Global Inc.. Compares

How Organigram Global Inc.. compares to Healthcare sector averages

Net Margin
OGI 0.0%
vs
Sector Avg 12.0%
OGI Sector
ROE
OGI 0.0%
vs
Sector Avg 15.0%
OGI Sector
Current Ratio
OGI 0.0x
vs
Sector Avg 2.0x
OGI Sector
Debt/Equity
OGI 0.0x
vs
Sector Avg 0.6x
OGI Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is Organigram Global Inc.. Stock Overvalued? OGI Valuation Analysis 2026

Based on fundamental analysis, Organigram Global Inc.. has mixed fundamental signals relative to the Healthcare sector in 2026.

Return on Equity
N/A
Sector avg: 15%
Net Profit Margin
N/A
Sector avg: 12%
Revenue Growth
N/A
Year-over-year
Debt/Equity
N/A
Sector avg: 0.6x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

Organigram Global Inc.. Balance Sheet: OGI Debt, Cash & Liquidity

Current Ratio
N/A
Quick Ratio
N/A
Debt/Equity
N/A
Debt/Assets
0.0%
Interest Coverage
N/A
Long-term Debt
N/A

OGI Revenue Growth, EPS Growth & YoY Performance

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
N/A
Free cash flow / Revenue

OGI SEC Filings: Latest 10-K & 10-Q Analysis

Access official SEC EDGAR filings for Organigram Global Inc.. (CIK: 0001620737)

📋 Recent SEC Filings

Date Form Document Action
Mar 19, 2021 SC 13D d157836dsc13d.htm View →
Nov 19, 2019 SC 13G sc13g1119etfmanag_organigram.htm View →
Jan 9, 2019 SC 13G s115296_sc13g.htm View →

Frequently Asked Questions about OGI

What is the AI rating for OGI?

Organigram Global Inc.. (OGI) has an AI grade of N/A with 0% confidence, based on fundamental analysis of SEC EDGAR filings.

What are OGI's key strengths?

Claude: Analysis in progress.

What are the risks of investing in OGI?

Claude: Analysis in progress.

What is OGI's revenue and growth?

Organigram Global Inc.. reported revenue of N/A.

Does OGI pay dividends?

Organigram Global Inc.. does not currently pay dividends.

Where can I find OGI SEC filings?

Official SEC filings for Organigram Global Inc.. (CIK: 0001620737) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is OGI's EPS?

Organigram Global Inc.. has a diluted EPS of $0.00.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.

What is OGI's fundamental grade?

Based on our AI fundamental analysis in July 2026, Organigram Global Inc.. has a N/A grade with 0% confidence. Review the strengths and risks sections above for full context. This is not investment advice.

Is OGI stock overvalued or undervalued?

Valuation metrics for OGI: ROE of N/A (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.

What is OGI's AI grade for 2026?

Our dual AI analysis gives Organigram Global Inc.. a combined N/A grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.

What is OGI's free cash flow?

Organigram Global Inc..'s operating cash flow is N/A, with capital expenditures of N/A.

How does OGI compare to other Healthcare stocks?

Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE N/A (avg: 15%), current ratio N/A (avg: 2).

Top Rated Stocks
AAPL 92% MSFT 92% FAST 92% ANET 88% RDDT 88% KNSL 88% MGRE 88% FIZZ 88% CRDO 87% AVGO 87%
Sector: All Healthcare Stocks →
Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Jul 13, 2026 | Data as of: 2026-07-13 | Powered by Claude AI